MC
PFE icon

Matisse Capital’s Pfizer PFE Stock Holding History

Matisse Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
14,000
+1,799
+15% +$47.1K 0.14% 124
2026
Q1 		$343K Buy
12,201
+539
+5% +$14.3K 0.15% 130
2025
Q4 		$290K Buy
11,662
+35
+0.3% +$883 0.13% 144
2025
Q3 		$296K Hold
11,627
– – 0.13% 146
2025
Q2 		$282K Buy
+11,627
New +$271K 0.13% 148
2025
Q1 		– Sell
-7,627
Closed -$202K – 172
2024
Q4 		$202K Buy
+7,627
New +$207K 0.1% 163
2024
Q2 		– Sell
-7,297
Closed -$202K – 192
2024
Q1 		$202K Buy
7,297
+191
+3% +$5.3K 0.1% 184
2023
Q4 		$205K Buy
+7,106
New +$215K 0.11% 183

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Matisse Capital's PFE Position: Q2 2026 in Review

Matisse Capital increased its Pfizer (PFE) stake by 15% in Q2 2026, buying an estimated $47.1K and bringing the position to 14,000 shares worth $337K. The position accounts for 0.14% of the portfolio, ranked #124.

Matisse Capital first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $343K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Matisse Capital held 14,000 shares of Pfizer worth $337K as of Q2 2026.
  • Matisse Capital bought 1,799 Pfizer shares in Q2 2026, an estimated $47.1K.
  • Pfizer made up 0.14% of Matisse Capital's portfolio in Q2 2026, its #124 holding.
  • Matisse Capital first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • Matisse Capital's Pfizer position peaked at $343K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Matisse Capital's 13F filing for Q2 2026, filed 12 Aug 2026.